The limitation of staged repair in the surgical management of congenital complex heart anomalies with aortic arch obstruction.
OBJECTIVE
Severe aortic arch obstruction including an interrupted aortic arch in congenital complex heart anomalies remains a challenge in surgical management.


METHODS
Treatment and outcomes in 75 consecutive patients who underwent an aortic arch repair as the first step of the staged repair protocol between 1975 and 2000 were reviewed. Their ages at repair ranged from 1 day to 8.5 months.


RESULTS
Cross-sectional postoperative follow-up data were available in all the patients. The follow-up period ranged from 0 to 27.6 years (mean: 7.3 +/- 7.3 years). There were 20 postoperative hospital deaths (27%) and 7 late deaths. The Kaplan-Meier estimate of survival was 81.3% +/- 4.5% at 1 month, 68.0% +/- 5.4% at 1 year, 65.0% +/- 5.5% at 5 years, 63.1% +/- 5.7% at 10 years, 63.1% +/- 5.7% at 20 years. By Cox regression analysis, body weight of 2.5 kg or less is the only independent determinant of postoperative mortality (p = 0.04, multivariable odds ratio: 2.50, [95% confidence interval: 1.02-6.1]). The aortic arch morphology, the primary cardiac lesion, or date of operation did not reach a statistically significant level to show correlation with mortality. Reintervention to reconstruct the aortic arch was performed at 9 occasions in 8 of the 55 patients who survived the primary operation (14.5%). The Kaplan-Meier estimate of the reintervention-free rate was 91.3% +/- 4.2% at 5 years, 85.5% +/- 5.6% at 10 years, 75.6% +/- 8.2% at 20 years. Using multivariable Cox regression analysis, interrupted aortic arch (versus aortic coarctation) was the only independent predictor of a shorter time to reintervention (p = 0.001, multivariable odds ratio: 16.1, [95% confidence interval: 3.2-80.2]).


CONCLUSIONS
The staged repair protocol was associated with significant limitations in patient survival and with the development of recurrent aortic arch obstruction. Thus, a primary repair protocol may serve as an alternate approach, especially in patients with low weight or with an interrupted aortic arch.
Aeba
Ryo
R
Division of Cardiovascular Surgery, Keio University, Tokyo, Japan.
Katogi
Toshiyuki
T
Hashizume
Kenichi
K
Iino
Yoshimi
Y
Koizumi
Kiyoshi
K
Hotoda
Kentaro
K
Inoue
Shinya
S
Matayoshi
Hideki
H
Yoshitake
Akihiro
A
Yozu
Ryohei
R
D000015:Abnormalities, Multiple / Q000401:mortality / Q000601:surgery*; D001015:Aortic Arch Syndromes / Q000401:mortality / Q000601:surgery*; D006348:Cardiac Surgical Procedures; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000401:mortality / Q000601:surgery*; D017052:Hospital Mortality; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007231:Infant, Newborn; D007564:Japan; D008297:Male; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality / Q000601:surgery; D011237:Predictive Value of Tests; D012086:Reoperation; D016896:Treatment Outcome